Introduction And Hypothesis: The urethra is surrounded by layers of smooth muscle, including inner longitudinal and outer circler muscles, as well as the skeletal muscle of the external urethral sphincter. However, the extent of these muscles and their relationship with the levator ani (LA) remain unclear. This study aimed to clarify the composition of muscle layers around the female urethra and their three-dimensional arrangements.
Methods: Pelvises from five female cadavers were collected for histological analysis. The surrounding urethral tissue was serially sectioned and stained with Elastica van Gieson stain to identify the connective and muscular tissues. Immunohistological staining with an anti-smooth muscle antibody was performed to confirm the distribution of the smooth and skeletal muscles. Thereafter, muscle layers were three-dimensionally reconstructed on the basis of serial histological sections.
Results: The female urethra was surrounded by four muscle layers arranged from inner to outer layers in the following order: longitudinal smooth muscle, circular smooth muscle, the external urethral sphincter (EUS), and an outermost smooth muscle layer. These muscles surrounded the urethra and partially extended anteriorly. Moreover, smooth muscle fibers extending from the vagina were found between the LA and EUS.
Conclusions: This study clarified the distribution of muscle tissue surrounding the female urethra, showing that the EUS is connected to the LA through the outermost smooth muscle layer. Thus, urination control likely involves both the urethral muscle layers and the pelvic floor muscles.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00192-025-06045-w | DOI Listing |
Virchows Arch
January 2025
Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Low-grade endometrial stromal sarcoma (LG-ESS) can present diagnostic challenges, due to its overlapping morphological features with other uterine mesenchymal tumors. Misdiagnosis rates remain significant, and immunohistochemical data for LG-ESS are limited to small series and inconsistent antibody panels. This study aimed to refine the IHC profile of LG-ESS by analyzing a large, molecularly confirmed series of 147 cases using a panel of 24 antibodies, including newer markers like transgelin and smoothelin.
View Article and Find Full Text PDFAm J Surg Pathol
January 2025
Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver BC, Canada.
Fumarate hydratase tumor predisposition syndrome (FHTPS) is caused by germline fumarate hydratase (FH) pathogenic variants (PVs). Most women with FHTPS develop FH-deficient (FHD) uterine leiomyomas (ULs), which arise 10 to 15 years earlier than aggressive FHD-renal cell carcinoma. We evaluate a previously proposed FHTPS screening strategy for women with ULs.
View Article and Find Full Text PDFiScience
January 2025
Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Diabetic vascular aging is driven by macrophage senescence, which propagates senescence-associated secretory phenotypes (SASP), exacerbating vascular dysfunction. This study utilized a type 2 diabetes mellitus (T2DM) mouse model induced by streptozotocin injection and a high-fat diet to investigate the role of STING in macrophage senescence. Vascular aging markers and senescent macrophages were assessed , while , high glucose treatment induced macrophage senescence, enhancing senescence in co-cultured vascular smooth muscle cells.
View Article and Find Full Text PDFFront Pharmacol
January 2025
Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Front Pharmacol
January 2025
National Clinical Research Center for TCM Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Background: Vascular calcification (VC) commonly occurs in diabetes and is associated with cardiovascular disease incidence and mortality. Currently, there is no drug treatment for VC. The Danlian-Tongmai formula (DLTM) is a traditional Chinese medicine (TCM) prescription used for diabetic VC (DVC), but its mechanisms of action remain unclear.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!